Cargando…
EZH2 Contributes to 5-FU Resistance in Gastric Cancer by Epigenetically Suppressing FBXO32 Expression [Retraction]
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Dove
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404417/ https://www.ncbi.nlm.nih.gov/pubmed/37551312 http://dx.doi.org/10.2147/OTT.S433399 |
| _version_ | 1785085293804650496 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10404417 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Dove |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104044172023-08-07 EZH2 Contributes to 5-FU Resistance in Gastric Cancer by Epigenetically Suppressing FBXO32 Expression [Retraction] Onco Targets Ther Retraction Dove 2023-08-02 /pmc/articles/PMC10404417/ /pubmed/37551312 http://dx.doi.org/10.2147/OTT.S433399 Text en © 2023 Dove Medical Press. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
| spellingShingle | Retraction EZH2 Contributes to 5-FU Resistance in Gastric Cancer by Epigenetically Suppressing FBXO32 Expression [Retraction] |
| title | EZH2 Contributes to 5-FU Resistance in Gastric Cancer by Epigenetically Suppressing FBXO32 Expression [Retraction] |
| title_full | EZH2 Contributes to 5-FU Resistance in Gastric Cancer by Epigenetically Suppressing FBXO32 Expression [Retraction] |
| title_fullStr | EZH2 Contributes to 5-FU Resistance in Gastric Cancer by Epigenetically Suppressing FBXO32 Expression [Retraction] |
| title_full_unstemmed | EZH2 Contributes to 5-FU Resistance in Gastric Cancer by Epigenetically Suppressing FBXO32 Expression [Retraction] |
| title_short | EZH2 Contributes to 5-FU Resistance in Gastric Cancer by Epigenetically Suppressing FBXO32 Expression [Retraction] |
| title_sort | ezh2 contributes to 5-fu resistance in gastric cancer by epigenetically suppressing fbxo32 expression [retraction] |
| topic | Retraction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404417/ https://www.ncbi.nlm.nih.gov/pubmed/37551312 http://dx.doi.org/10.2147/OTT.S433399 |